LeMaitre Vascular, Inc. (LMAT) vs STAAR Surgical Company (STAA)
- LeMaitre Vascular, Inc. LMAT 80.82 −2.81%
- STAAR Surgical Company STAA 21.27 −4.45%
LeMaitre Vascular, Inc. and STAAR Surgical Company are both Medical Instruments & Supplies companies. LeMaitre Vascular, Inc. is the larger, with a market value of $1.9B against $1.1B — 1.7× the size. LeMaitre Vascular, Inc. trades at the lower P/E: 27.9× against 304×. STAAR Surgical Company grew revenue faster over the last twelve months: 51.3% against 11.9%. LeMaitre Vascular, Inc. has the higher net margin (25.0% vs 1.13%) and the higher return on invested capital (22.7% vs 4.67%). Across the 21 metrics below, LeMaitre Vascular, Inc. leads on 15 and STAAR Surgical Company on 6.
Valuation
Profitability
| Metric | LMAT | STAA | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 72.90% | 76.62% | 54.29% |
| Operating margin | 29.46% | 4.04% | 1.07% |
| Net margin | 25.02% | 1.13% | (1.61%) |
| Free cash flow margin | 28.13% | (1.99%) | 1.08% |
| Return on equity | 16.77% | 1.09% | (1.32%) |
| Return on assets | 10.78% | 0.84% | 0.00% |
| Return on invested capital | 22.67% | 4.67% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack